Literature DB >> 3980478

Acetylcholinesterase from fetal bovine serum. Purification and characterization of soluble G4 enzyme.

J S Ralston, R S Rush, B P Doctor, A D Wolfe.   

Abstract

Acetylcholinesterase (EC 3.1.1.7) from fetal bovine serum (FBS) was purified to electrophoretic homogeneity. The procedure involved procainamide affinity chromatography with native FBS, followed by chromatography on Sepharose 6B and DEAE-Sephadex. The acetylcholinesterase was purified approximately 44,000-fold, and 13 mg was obtained corresponding to an overall yield of about 45%. The purified acetylcholinesterase was stable at 4 degrees C for at least 8 weeks but was labile to freezing; however, in 50% glycerol the enzyme was stable at -20 degrees C for at least 12 weeks. FBS acetylcholinesterase exhibited typical substrate inhibition, had a Km of 120 microM, and a turnover number of 5300 s-1 with the substrate acetylthiocholine. The enzyme was highly sensitive to the specific acetylcholinesterase inhibitor 1,5-bis(4-allyldimethylammoniumphenyl)pentan-3-one. FBS acetylcholinesterase was characterized as a G4 form of acetylcholinesterase and was distinguished from bovine erythrocyte acetylcholinesterase on the basis of lectin gel binding, [3H] Triton X-100 binding, amino acid composition, number of catalytic subunits/molecule, and hydrodynamic properties. FBS acetylcholinesterase had a Stokes radius of 76 A as judged by gel filtration, and from this a molecular weight of 340,000 daltons was calculated. The enzyme had a subunit weight of approximately 83,000 daltons by sodium dodecyl sulfate-polyacrylamide gel electrophoresis; paraoxon titration indicated a relative active site mass of 75,000 daltons. The amino acid composition of FBS acetylcholinesterase was similar to the human erythrocyte acetylcholinesterase (Rosenberry, T. L., and Scoggin, D. M. (1984) J. Biol. Chem. 259, 5643-5652). A monoclonal antibody directed against human erythrocyte acetylcholinesterase, AE-2, (Fambrough, D. M., Engel, A. G., and Rosenberry, T. L. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 1078-1082) cross-reacted with FBS acetylcholinesterase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3980478

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

Review 1.  Comparison of butyrylcholinesterase and acetylcholinesterase.

Authors:  A Chatonnet; O Lockridge
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

2.  Characterization of butyrylcholinesterase in bovine serum.

Authors:  Alicia J Dafferner; Sofya Lushchekina; Patrick Masson; Gaoping Xiao; Lawrence M Schopfer; Oksana Lockridge
Journal:  Chem Biol Interact       Date:  2017-02-08       Impact factor: 5.192

3.  Effect of human acetylcholinesterase subunit assembly on its circulatory residence.

Authors:  T Chitlaru; C Kronman; B Velan; A Shafferman
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

4.  Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation.

Authors:  C Kronman; B Velan; D Marcus; A Ordentlich; S Reuveny; A Shafferman
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

5.  Comparative studies on the primary structure of acetylcholinesterases from bovine caudate nucleus and bovine erythrocytes.

Authors:  H Heider; P Litynski; S Stieger; U Brodbeck
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

6.  Forskolin, an inducer of cAMP, up-regulates acetylcholinesterase expression and protects against organophosphate exposure in neuro 2A cells.

Authors:  Bryan F Curtin; Nabaneeta Pal; Richard K Gordon; Madhusoodana P Nambiar
Journal:  Mol Cell Biochem       Date:  2006-08-19       Impact factor: 3.396

7.  Recombinant human acetylcholinesterase is secreted from transiently transfected 293 cells as a soluble globular enzyme.

Authors:  B Velan; C Kronman; H Grosfeld; M Leitner; Y Gozes; Y Flashner; T Sery; S Cohen; R Ben-Aziz; S Seidman
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

8.  Polyproline tetramer organizing peptides in fetal bovine serum acetylcholinesterase.

Authors:  Kevser Biberoglu; Lawrence M Schopfer; Ashima Saxena; Ozden Tacal; Oksana Lockridge
Journal:  Biochim Biophys Acta       Date:  2013-01-23

9.  The impact of crystallization conditions on structure-based drug design: A case study on the methylene blue/acetylcholinesterase complex.

Authors:  Orly Dym; Wanling Song; Clifford Felder; Esther Roth; Valery Shnyrov; Yacov Ashani; Yechun Xu; Robbie P Joosten; Lev Weiner; Joel L Sussman; Israel Silman
Journal:  Protein Sci       Date:  2016-03-28       Impact factor: 6.725

10.  Bovine acetylcholinesterase: cloning, expression and characterization.

Authors:  I Mendelson; C Kronman; N Ariel; A Shafferman; B Velan
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.